128 related articles for article (PubMed ID: 35665660)
1. Clostridium haemolyticum, a review of beta toxin and insights into the antigen design for vaccine development.
Alves MLF; Ferreira MRA; Rodrigues RR; Conceição FR
Mol Immunol; 2022 Aug; 148():45-53. PubMed ID: 35665660
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants.
Moreira GM; Salvarani FM; da Cunha CE; Mendonça M; Moreira ÂN; Gonçalves LA; Pires PS; Lobato FC; Conceição FR
Sci Rep; 2016 Mar; 6():22816. PubMed ID: 27004612
[TBL] [Abstract][Full Text] [Related]
3. Potential protective immunogenicity of recombinant Clostridium perfringens α-β2-β1 fusion toxin in mice, sows and cows.
Zeng J; Deng G; Wang J; Zhou J; Liu X; Xie Q; Wang Y
Vaccine; 2011 Jul; 29(33):5459-66. PubMed ID: 21641956
[TBL] [Abstract][Full Text] [Related]
4. Immunization of sheep with a recombinant vaccine containing immunogenic nontoxic domains of Clostridium perfringens alpha and beta toxins.
Rodrigues Rodrigues R; Freitas Motta J; Alves Ferreira MR; Moreira Júnior C; Ferreira Alves ML; Costa AV; Andrade Bilhalva M; Amaral Donassolo R; Cancela Galvão C; Silva Martins FM; Masiero Salvarani F; Rochedo Conceição F
Microb Pathog; 2023 Sep; 182():106269. PubMed ID: 37516212
[TBL] [Abstract][Full Text] [Related]
5. Inactivated recombinant Escherichia coli as a candidate vaccine against Clostridium perfringens alpha toxin in sheep.
Ferreira MRA; Motta JF; Azevedo ML; Dos Santos LM; Júnior CM; Rodrigues RR; Donassolo RA; Reis ADSB; Barbosa JD; Salvarani FM; Moreira ÂN; Conceição FR
Anaerobe; 2019 Oct; 59():163-166. PubMed ID: 31299397
[TBL] [Abstract][Full Text] [Related]
6. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C.
Neeson BN; Clark GC; Atkins HS; Lingard B; Titball RW
Microb Pathog; 2007 Oct; 43(4):161-5. PubMed ID: 17604945
[TBL] [Abstract][Full Text] [Related]
7. Immunization of mice against alpha, beta, and epsilon toxins of Clostridium perfringens using recombinant rCpa-b-x expressed by Bacillus subtilis.
Wang Y; Miao Y; Hu LP; Kai W; Zhu R
Mol Immunol; 2020 Jul; 123():88-96. PubMed ID: 32447084
[TBL] [Abstract][Full Text] [Related]
8. Measurement over 1 Year of Neutralizing Antibodies in Cattle Immunized with Trivalent Vaccines Recombinant Alpha, Beta and Epsilon of
Galvão CC; Barbosa JD; Oliveira CMC; Otaka DY; Silva PRO; Ferreira MRA; Moreira Júnior C; Conceição FR; Salvarani FM
Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564599
[TBL] [Abstract][Full Text] [Related]
9. A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens.
Nagahama M; Oda M; Kobayashi K; Ochi S; Takagishi T; Shibutani M; Sakurai J
Microbiol Immunol; 2013 May; 57(5):340-5. PubMed ID: 23668605
[TBL] [Abstract][Full Text] [Related]
10. Generation of recombinant baculovirus expressing atoxic C-terminal CPA toxin of Clostridium perfringens and production of specific antibodies.
Forti K; Cagiola M; Pellegrini M; Anzalone L; Di Paolo A; Corneli S; Severi G; De Giuseppe A
BMC Biotechnol; 2020 Jan; 20(1):7. PubMed ID: 31992276
[TBL] [Abstract][Full Text] [Related]
11. The C-terminal domain of Clostridium perfringens alpha toxin as a vaccine candidate against bovine necrohemorrhagic enteritis.
Goossens E; Verherstraeten S; Valgaeren BR; Pardon B; Timbermont L; Schauvliege S; Rodrigo-Mocholí D; Haesebrouck F; Ducatelle R; Deprez PR; Van Immerseel F
Vet Res; 2016 Apr; 47(1):52. PubMed ID: 27121298
[TBL] [Abstract][Full Text] [Related]
12. Toxin-neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritis.
Goossens E; Verherstraeten S; Valgaeren BR; Pardon B; Timbermont L; Schauvliege S; Rodrigo-Mocholí D; Haesebrouck F; Ducatelle R; Deprez PR; Van Immerseel F
BMC Vet Res; 2016 Jun; 12(1):101. PubMed ID: 27297520
[TBL] [Abstract][Full Text] [Related]
13. Molecular variation between the alpha-toxins from the type strain (NCTC 8237) and clinical isolates of Clostridium perfringens associated with disease in man and animals.
Ginter A; Williamson ED; Dessy F; Coppe P; Bullifent H; Howells A; Titball RW
Microbiology (Reading); 1996 Jan; 142 ( Pt 1)():191-198. PubMed ID: 8581165
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Alpha, Beta, and Epsilon Toxins of Clostridium perfringens: Production Strategies and Applications as Veterinary Vaccines.
Ferreira MR; Moreira GM; Cunha CE; Mendonça M; Salvarani FM; Moreira ÂN; Conceição FR
Toxins (Basel); 2016 Nov; 8(11):. PubMed ID: 27879630
[No Abstract] [Full Text] [Related]
15. Non-toxic perfringolysin O and α-toxin derivatives as potential vaccine candidates against bovine necrohaemorrhagic enteritis.
Verherstraeten S; Goossens E; Valgaeren B; Pardon B; Timbermont L; Haesebrouck F; Ducatelle R; Deprez P; Van Immerseel F
Vet J; 2016 Nov; 217():89-94. PubMed ID: 27810219
[TBL] [Abstract][Full Text] [Related]
16. Immunization with recombinant bivalent chimera r-Cpae confers protection against alpha toxin and enterotoxin of Clostridium perfringens type A in murine model.
Shreya D; Uppalapati SR; Kingston JJ; Sripathy MH; Batra HV
Mol Immunol; 2015 May; 65(1):51-7. PubMed ID: 25645504
[TBL] [Abstract][Full Text] [Related]
17. Vaccines against Clostridium perfringens alpha-toxin.
Nagahama M
Curr Pharm Biotechnol; 2013; 14(10):913-7. PubMed ID: 24372250
[TBL] [Abstract][Full Text] [Related]
18. Oral vaccination of broiler chickens against necrotic enteritis using a non-virulent NetB positive strain of Clostridium perfringens type A.
Mishra N; Smyth JA
Vaccine; 2017 Dec; 35(49 Pt B):6858-6865. PubMed ID: 29102330
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the expression and immunogenicity of four versions of recombinant Clostridium perfringens beta toxin designed by bioinformatics tools.
Rodrigues RR; Alves Ferreira MR; Donassolo RA; Ferreira Alves ML; Motta JF; Junior CM; Salvarani FM; Moreira AN; Conceicao FR
Anaerobe; 2021 Jun; 69():102326. PubMed ID: 33508438
[TBL] [Abstract][Full Text] [Related]
20. Naturally occurring Clostridium perfringens nontoxic alpha-toxin variant as a potential vaccine candidate against alpha-toxin-associated diseases.
Schoepe H; Pache C; Neubauer A; Potschka H; Schlapp T; Wieler LH; Baljer G
Infect Immun; 2001 Nov; 69(11):7194-6. PubMed ID: 11598102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
